CION Cancer Clinics
Liver failure after TACE: who is at risk and how it is avoided | CION Cancer Clinics
TACE can cause liver failure, but it is uncommon when the liver is working well before treatment. The risk rises sharply when the liver is already scarred, when tumours fill much of it, or when the portal vein is blocked. This page explains who is at higher risk, how the team protects the liver, which blood tests to watch and which signs after TACE mean going to hospital today. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
On this page
- Can TACE cause liver failure?
- Who is more likely to have liver problems after TACE?
- What does the team do to protect the liver?
- Which blood test results show how the liver is coping?
- What do families often get wrong about TACE and the liver?
- What can this page not tell you?
- Common questions about liver failure after TACE
The short answer
Can TACE cause liver failure?
Yes, it can, but it is uncommon when the right people are chosen. The risk is highest in people whose liver was already struggling before the procedure, and that is why the team checks liver function so carefully first. For most people with a well-working liver, the liver recovers after a short dip in the blood tests.
Why a treatment for the tumour can strain the liver
TACE (transarterial chemoembolisation) delivers chemotherapy into the artery feeding the tumour and then blocks that artery. The tumour depends on this artery. The healthy liver mostly does not, because it also draws blood from the portal vein. But some normal liver around the tumour is always caught in the blocked area. If the liver has little spare capacity, losing even that small part can tip it over.
Who this page is for
This page is about primary liver cancer, usually hepatocellular carcinoma (HCC), in someone who has been offered TACE. If the cancer in your liver started somewhere else, such as the bowel, the balance of risk is different and the page on TACE for liver metastases is the better starting point.
Liver failure after TACE is rare in a good liver. It is the reason a weak liver is often steered away from TACE.What raises the risk
Who is more likely to have liver problems after TACE?
The team weighs three things together: how well the liver works, how much of it the tumour takes up, and whether the blood flow around it is intact.
A liver already under strain
Cirrhosis means scarring of the liver. The more advanced it is, the less reserve the liver has. Child-Pugh is the score doctors use for this, and the Child-Pugh page explains it in plain words.
Signs of a strained liver
- Raised bilirubin, the yellow pigment that causes jaundice
- Low albumin, a protein the liver makes
- Fluid in the abdomen (ascites)
- Past episodes of confusion from the liver
A large share of the liver involved
When tumours fill much of the liver, more normal tissue sits in the treated area. Treating everything at once is riskier, so the work may be split into smaller, targeted sessions.
A blocked portal vein
If tumour has grown into the main portal vein, the healthy liver loses its main back-up blood supply. Blocking the artery as well can starve normal liver. Many teams avoid standard TACE here.
Other health problems
Poor kidney function, an active infection, a blocked bile duct or a recent bleed all make recovery harder. These are usually treated or settled first.
None of these is a matter of fault. They are simply what the liver has been through.Not sure whether this applies to you?
Ask an oncologistAfter TACE, go to hospital today if you notice new confusion or unusual drowsiness, vomiting blood or black stools, a fever with shivering, yellow eyes that are quickly getting worse, or a belly that is swelling fast. Tell the staff you had TACE and when. Do not wait for the next clinic visit, and do not treat it at home first. The page on confusion and drowsiness explains why that sign matters.
Keeping the risk low
What does the team do to protect the liver?
Checking liver function first
Blood tests for bilirubin, albumin and clotting, plus a look for fluid or past confusion, give a picture of the liver's reserve. The tumour board reviews these with the scan before TACE is offered.
Treating only what needs treating
The interventional radiologist at the partner hospital passes the catheter as close to the tumour as possible. This is called selective TACE, and it spares more of the normal liver.
Splitting the work
When there are tumours on both sides of the liver, they may be treated in separate sessions, a few weeks apart. That gives the liver time to recover between them.
Repeating the blood tests
Liver tests are checked again after the procedure and before any further session. If the liver has not bounced back, the next session is delayed or a different treatment is chosen.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
Which blood test results show how the liver is coping?
- Bilirubin
- A yellow pigment the liver clears. A rise after TACE is common and usually settles. A steady climb is the result doctors watch most.
- Albumin
- A protein made by the liver. Low albumin suggests the liver has less in reserve, and is one reason families should not cut protein from the diet.
- INR
- A clotting test. The liver makes clotting proteins, so a rising INR can mean it is struggling.
- ALT and AST
- Enzymes released when liver cells are damaged. They often jump after TACE because the tumour and some nearby tissue are injured. A short rise on its own is expected.
- Liver decompensation
- The point where the liver can no longer keep up, shown by jaundice, ascites, confusion or bleeding. This is what "liver failure" means on a report.
Commonly believed
What do families often get wrong about TACE and the liver?
A rise in liver enzymes soon after TACE is expected, because the treatment deliberately damages tumour cells. What matters is whether bilirubin keeps rising and whether new symptoms appear. Your team will tell you which results to worry about.
Each session takes a little from the liver. Over several sessions, liver function can slowly fall. This is why the team rechecks before every repeat, and why TACE is sometimes stopped even when the tumour is still there.
It means the liver needs a gentler approach. Depending on the tumour and the liver, the team may look at systemic treatment, radiation, or symptom-focused care. A no to TACE is a reason to ask what comes next.
The opposite is usually true. A recovering liver needs enough protein, and cutting it can weaken the body. Ask the team or a dietitian before changing the diet.
Being straight with you
What can this page not tell you?
It cannot tell you your own risk. That depends on your blood results, your scan, how much liver the tumour involves and how the portal vein looks. Only the team that has seen all of these can weigh them, and the page on when TACE is not safe sets out the common reasons they say no.
Who this does not apply to
If your liver is already badly scarred, with jaundice, fluid or confusion, TACE is usually not suitable at all, and this page describes a risk you are unlikely to be offered. If your cancer spread to the liver from the bowel or elsewhere, and the liver itself is healthy, the risk of liver failure after TACE is generally lower.
Who can answer it
Your medical oncologist and the hepatologist together. At CION, the tumour board reviews the liver tests and scans, and CION coordinates TACE through NABH-accredited partner hospitals. Your team will tell you where the procedure takes place.
Bring every recent liver test report to the consultation. The trend matters more than any single value.Questions we are asked
Common questions about liver failure after TACE
How common is liver failure after TACE?
It is uncommon in people with a well-working liver who are carefully selected. It becomes more likely as liver function gets weaker. Your team can explain where you sit, using your own blood tests and scan, which is far more useful than any general figure.
Is fever and pain after TACE a sign of liver failure?
Usually not. Mild fever, pain on the right side and nausea are common after TACE and are called post-embolisation syndrome. They usually ease within a week. A high fever with shivering, new confusion or worsening jaundice is different, and means hospital today.
Can the liver recover if it gets worse after TACE?
Often, yes. Many people have a short dip in liver tests that recovers over the following weeks. When the liver does decompensate, it may recover with supportive care, but sometimes it does not fully return to where it was. That is why selection matters so much.
Does Child-Pugh B mean I cannot have TACE?
Not always. Some people at the milder end of Child-Pugh B are offered a very targeted TACE after careful discussion. Others are better served by a different approach. This is exactly the kind of decision the tumour board weighs, using the full picture rather than the score alone.
Will more TACE sessions damage my liver further?
They can. Each session takes a little from the liver, so the team checks liver function before every repeat. If it is falling, or the tumour is not responding, they may stop TACE and suggest a different treatment rather than continuing.
What should I watch for after going home?
Yellowing that is getting worse, a swelling belly, confusion or sleepiness, vomiting blood, black stools, or fever with shivering. Any of these means hospital today. Ordinary tiredness and mild pain that slowly improves are expected, and can wait for your follow-up visit.
Is TARE safer for the liver than TACE?
It can suit some situations better, such as when the portal vein is involved, but it has its own liver risks and is not simply the safer choice. The TACE versus TARE page explains how the team chooses between them.
Can hepatitis B flare after TACE?
Yes. The chemotherapy in TACE can reactivate hepatitis B, which itself can strain the liver. If you carry hepatitis B, tell your team. Antiviral tablets are often started before TACE, and that decision belongs to your hepatologist or physician.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Embolization Therapy for Liver Cancer
- American Cancer Society — Treatment of Liver Cancer, by Stage
- MedlinePlus — Liver Function Tests
- Liver UK (formerly British Liver Trust) — Hepatic encephalopathy (HE)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Worried your liver is not strong enough for TACE?
Send us your latest liver tests and scan, and the tumour board can review whether TACE suits your liver or another approach would be safer. One helpline serves every CION centre.